ICIG Acquires CordenPharma Colorado from Roche

Press Release > International Chemical Investors Group Announces Acquisition of CordenPharma Colorado from Roche

We are pleased to announce that on September 1, 2011 International Chemical Investors Group (ICIG) acquired a former division of Roche to join their pharmaceutical platform CordenPharma International as CordenPharma Colorado. Under the terms of the agreement CordenPharma Colorado will maintain primary operations in their Boulder, Colorado manufacturing facility.

With over 65 years of experience in the fine chemical and contract manufacturing industry, CordenPharma Colorado manufactures peptides, active compounds and small molecules in an FDA approved cGMP facility.

From technologies such as FUZEON^®, a highly complex peptide molecule synthesized on a large scale, to innovative process design and scale-up, extensive small molecule equipment, regulatory expertise, clinical materials and the only metric ton peptide production facility in the industry, CordenPharma Colorado brings unparalleled expansion to CordenPharma’s synergistic drug development and contract manufacturing offerings.